… Thrombus formation on intracardiac devices remains a … 1 and 2 and thrombin-antithrombin
III. In contrast, factors … course of low molecular weight heparin (LMWH) or addition of a …

… trial of enoxaparin compared to no anticoagulation therapy in … antithrombotic therapy
should be considered to avoid … therapy in a nonrandomized fashion after 2 weeks of injectable …

… platelet, will be addressed in a following section, given its critical … The LMWH derivatives
have found use in prophylaxis for a … antithrombotic therapies—drugs that can remarkably impact …

… At the end of LMWH, combined with oral warfarin therapy … for transient macroscopic
hemoglobinuria taking place after the … as an adjunct to antithrombotic therapy for acute proximal …

… field of thrombosis and antithrombotic therapies began quite … transluminal angioplasty
prosthetic valve thrombosis or … thrombus from STEMI patients within the first hours after the …

… Clot formation and maintenance are influenced by a various factors … Macroscopic analyses
of deposition, platelet adhesion and … of balloon angioplasty, to keep the artery open after the …

… ], both UFH and LMWH are unable to inactivate clot-bound … matrices and other macroscopic
surfaces. Covalent attachment of … ATH and antithrombin from unreacted LMWH, followed by …

… These devices constantly pump blood throughout the body … After reacting the anti-thrombin
drug enoxaparin sodium (ES) … -coated surfaces had widespread clot formations, but the ES …

… from this kind of thrombus, after migration of smooth muscle … catheters—has described
thrombus formation in 24% of FS. … be an indication to antithrombotic prophylaxis. This might be …

… Protein S deficiency and antithrombin III deficiency were detected 60.7% and 58.3% of BCS
… man with BCS transplanted after Trans-arterial chemoembolization. a Macroscopic view of a …